Dr. Raj K. Batra

David Geffen School of Medicine




1988  M.D., University of Toledo College of Medicine & Life Sciences

1983  B.Sc., Ohio State University

Publications (selected)

  1. Batra RK, S. Oh and SK Basak.  The isolation and molecular characterization of cancer stem cells (aggressive endophenotypes) in individual lung cancers.  In Stem Cells, Tissue Engineering and Regenerative Medicine. Edited by David Warburton. Imperial College Press, London, UK 2014.
  2. Veena MS, R Wilken, JY Zheng, A Gholkar, D Vira, S Ahmed, SK Basak, RK Batra, N Kasahara, D Elashoff , MC Fishbein, JP Whitelegge, JZ Torres, MB Wang, ES Srivatsan. p16 recruits gigaxonin for NFκB ubiquitination in cisplatin induced senescence.  J Biol Chem. 2014, Dec 12; 289(50):34921-37. [Epub ahead of print Oct 20]. (PMID: 25331947).
  3. Basak SK,  MS Veena, S Oh, C Lai, S Vangala, D Elashoff , MC Fishbein, S Sharma, NP Rao, D Rao, R Phan, ES Srivatsan, and RK Batra. The CD44high tumorigenic subsets in lung cancer biospecimens are enriched for low miR-34a expression. PLoS One. 2013 Sep 3; 8(9): e73195. (PMC: 3790883).
  4. Batra RK, Soo Hoo GW.  Reprogrammed cells for respiratory papillomatosis (Letter).  N Engl J Med.  2012, Dec 27; 367(26): 2553-4. (PMID: 23268676).
  5. Darshni Vira, SK. Basak, MS. Veena, MB. ang, RK. Batra*, and ES Srivatsan,* Cancer stem cells, microRNAs, and therapeutic strategies, including natural products. Cancer and Metastases Reviews. (*Co-corresponding author). 2012 Dec; 31(3-4): 733-51. (PMID: 22752409).
  6. Frey MR, Carraro G, Batra RK, Polk DB, Warburton D. Sprouty keeps bowel kinases regular in colon cancer, while miR-21 targets Sprouty. Cancer Biol Ther. 2011 Jan 1; 11(1): 112-114. (PMID: 21124074).
  7. Batra RK and D Warburton.  On the derivation and clinical implications of “driver” mutations in lung cancer.  Am J Resp. and Critical Care Med. 2010 July (182). pp. 4-5, (Invited Editorial). (PMID: 20463175).
  8. Limsukon A, I Susanto, G Soo Hoo, SM Dubinett, and RK Batra. Regression of recurrent respiratory papillomatosis with celecoxib and erlotinib combination therapy CHEST 2009 Sept. (136): 924-926. (PMID: 19736197).
  9. Veena MS, M Qin, A Andersson, S Sharma, and RK Batra.  CAR mediates efficient tumor engraftment of mesenchymal type lung cancer cells. Lab. Invest.  2009 Aug; 89(8): 875-86. (PMID: 19506548).
  10. Basak SK, MS Veena, S Oh, G Huang, E Srivatsan, M Huang, S Sharma, and RK Batra.  The malignant pleural effusion as a model to investigate intratumoral heterogeneity in lung cancer.  PLoS ONE.  2009, Jun 12; 4(6): e5884.  (PMC: 2697051).
  11. Andersson A, SC Yang, M Huang, L Zhu, UK Kar, RK Batra, D Elashoff, RM Strieter, SM Dubinett, and S Sharma. IL-7 Promotes CXCR3 Ligand-Dependent T Cell Antitumor Reactivity in Lung Cancer. J Immunol. 2009 Jun 1; 182(11): 6951-8.
  12. Baratelli F, H Takedatsu, S Hazra, K Peebles, J Luo, PS Kurimoto, G Zeng, RK Batra, S Sharma, SM Dubinett, JM Lee. Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non- Small Cell Lung Cancer. J Translational Med. 2008 Jul 22; 6(1): 38. (PMC: 2507704).
  13. Hazra S, RK Batra, HH Tai, S Sharma S, X Cui, SM Dubinett. Pioglitazone and Rosiglitazone decrease PGE2 in non-small cell lung cancer cells by upregulating 15-hydroxyprostaglandin dehydrogenase. Mol Pharmacol. 2007 Jun; 71(6): 1715-20.
  14. Dohadwala M, SC Yang, J Luo, S Sharma, RK Batra, M Huang, Y Lin, L Goodglick, K Krysan, MC Fishbein, L Hong, C Lai, RB Cameron, RM Gemmill, HA Drabkin, SM Dubinett. Cyclooxygenase-2- Dependent Regulation of E-Cadherin: Prostaglandin E2 Induces Transcriptional Repressors ZEB1 and Snail in Non-Small Cell Lung Cancer. Cancer Res. 2006 May 15; 66(10): 5338-45.
  15. Hillinger S, SC Yang, RK Batra, RM Strieter, W Weder, SM Dubinett, S Sharma. CCL19 reduces tumor burden in a model of advanced lung cancer. Br J Cancer. 2006 Apr 10; 94(7): 1029-34. (PMC: 2361223).
  16. Yang SC, RK Batra, S Hillinger, KL Reckamp, RM. Strieter, SM. Dubinett, and S Sharma. Intrapulmonary Administration of CCL21 Gene-Modified Dendritic Cells Reduces Tumor Burden in Spontaneous Murine Bronchoalveolar Cell Carcinoma. Cancer Res. 2006, 66: 3205-3213.
Free SCIRP Newsletters
Copyright © 2006-2023 Scientific Research Publishing Inc. All Rights Reserved.